JB Chemicals & Pharmaceuticals has informed that Company's API manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by US FDA with two minor procedural observations. These observations do not impact continuity of Company's business and the Company would continue its manufacturing activities in CGMP compliant manner. The Company proposes to address these observations in next 30 days. The said inspection was carried out from 7-5-2018 to 11-5-2018. This US FDA/EU/Japan approved API facility primarily manufactures APIs for exports to EU and formulations exports to US.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: